Truvada

Trump Administration Sues Drug Company Over HIV Drug Truvada

Gilead Sciences made $3 billion selling the drug, used to prevent the spread of HIV, last year.

By

Directory Listing PrEP Providers Across The U.S. Is Now Available

By Savas Abadsidis, HIV Plus Mag

Here's Why Anti-HIV Drugs May Not Be Reaching Those Most At Risk

Unequal use of Truvada may worsen the disparities between races in HIV rates, a study found.

By Reuters, Andrew M. Seaman

Revisiting "Truvada Whore," Three Years Later

By LOGO

Man Sues After Being Denied Long-Term Care Insurance Due To Truvada Use

By Dominic Preston, Frontiers Media

How San Francisco Is Taking On HIV, And Succeeding

San Fran has become a national leader at fighting the HIV/AIDS epidemic.

By

Truvada Protected 100 Percent Of Study Participants From HIV

This is exciting!

By

Why Isn’t Revolutionary HIV Medication PrEP Getting to Sex Workers?

By Caelainn Hogan, VICE

Why The HIV Prevention Drug, PrEP, Remains So Divisive Among The LGBT Community

By